Transfusion-associated graft versus host disease natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Transfusion-associated graft versus host disease}} {{CMG}} ==Overview== == Complications == The most common cause of death in TA-GvHD is aplastic anemia. =...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
{{Transfusion-associated graft versus host disease}} | {{Transfusion-associated graft versus host disease}} | ||
{{CMG}} | {{CMG}} | ||
Line 13: | Line 15: | ||
[[Category:Transfusion medicine]] | [[Category:Transfusion medicine]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Needs content]] |
Latest revision as of 19:09, 21 September 2012
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Transfusion-associated graft versus host disease Microchapters |
Differentiating Transfusion-associated graft versus host disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Transfusion-associated graft versus host disease natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Transfusion-associated graft versus host disease natural history, complications and prognosis |
FDA on Transfusion-associated graft versus host disease natural history, complications and prognosis |
CDC on Transfusion-associated graft versus host disease natural history, complications and prognosis |
Directions to Hospitals Treating Transfusion-associated graft versus host disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Complications
The most common cause of death in TA-GvHD is aplastic anemia.